Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 157 Carcinoma, Intraductal, Noninfiltrating 16 Breast Carcinoma In Situ 12 Neoplasm Metastasis 9 Ovarian Neoplasms 7 Breast Neoplasms, Male 7 Neoplasms 4 Prostatic Neoplasms 3 Inflammatory Breast Neoplasms 3 Glioblastoma 3 Breast Cancer Female 3 Urinary Bladder Neoplasms 2 Recurrence 2 Pancreatic Neoplasms 2 Obesity 2 Infertility 2 Hot Flashes 2 Fibroadenoma 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2 ER+ Breast Cancer 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Sleep Wake Disorders 1 Sexuality 1 Risk Reduction Behavior 1 Rhabdoid Tumor 1 Pyloric Stenosis, Hypertrophic 1 Primary Breast Cancer 1

Interventions

pembrolizumab 1 exemestane 1 Tamoxifen 1 Surgical Procedures, Operative 1 Leuprolide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Premenopausal Breast Cancer × Tamoxifen × Clear all

NCT04997941 2024-04-23

MORE-T

Seoul National University Hospital

Phase 2 Active not recruiting

Premenopausal Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡